As antibiotic-resistant infections rise and are projected to cause up to 10 million deaths per year by 2050, scientists are ...

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

Funding to support Phase 1 clinical development of best-in-class PARG inhibitor candidate FORX-428FORX-428 is potential new ...

The arrest and prosecution of Chinese researcher Youhuang Xiang, announced December 19 by FBI Director Kash Patel, is the ...

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing targeted oligonucleotide therapies for functional cure of chronic ...

TAIPEI and SAN DIEGO, Dec. 23, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage companies focusing on development of first-in-class therapeutics for oncology, rare diseases ...

Mycosis fungoides is the most common subtype, making up the vast majority of CTCL cases. While early-stage disease has an estimated five-year survival rate of 88%, it remains a difficult-to-manage ...

WBSSC 2nd SLST 2025: The West Bengal School Service Commission (WBSSC) has released the Oral Interview and Lecture Demonstration schedule for the 2nd SLST (AT), 2025 for Class XI–XII Assistant ...

A research group has demonstrated that overexpression of Cdc10-dependent transcript 1 (CDT1), a key regulator of DNA replication initiation, induces DNA damage and potentially results in genetic ...

Forbes contributors publish independent expert analyses and insights. Matthew F. Erskine is a trusts and estates attorney. Imagine opening a birthday gift DNA kit and discovering you're entitled to ...